there were no significant differences in the concentrations of the monoamine metabolites in the csf between the two patient groups studied despite the fact that the group of lobotomized schizophrenics had significantly more central and cortical brain atrophy than the group of nonlobotomized schizophrenic patients .
C0086045
concentrations
C0006104
brain